{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:49:19Z","timestamp":1792288159226,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["2025ZX022"],"award-info":[{"award-number":["2025ZX022"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Global Medical Genetics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.gmg.2026.100124","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:41:48Z","timestamp":1785800508000},"page":"100124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["RUNX1 upregulation and RUNX1-ETO depletion inhibits survival of t(8;21)-positive leukemia cells"],"prefix":"10.1016","volume":"13","author":[{"given":"Junshi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gmg.2026.100124_bib1","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.2741\/3977","article-title":"RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis","volume":"17","author":"Lam","year":"2012","journal-title":"Front. Biosci. (Landmark Ed. )"},{"key":"10.1016\/j.gmg.2026.100124_bib2","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","article-title":"Role of RUNX1 in hematological malignancies","volume":"129","author":"Sood","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.gmg.2026.100124_bib3","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1038\/s41388-021-01952-w","article-title":"AML1\/ETO and its function as a regulator of gene transcription via epigenetic mechanisms","volume":"40","author":"Rejeski","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.gmg.2026.100124_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2020.11.005","article-title":"The RUNX1\/RUNX1T1 network: translating insights into therapeutic options","volume":"94","author":"Swart","year":"2021","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.gmg.2026.100124_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ccell.2019.03.012","article-title":"The Oncogenic Transcription Factor RUNX1\/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation","volume":"35","author":"Martinez-Soria","year":"2019","journal-title":"Cancer Cell."},{"key":"10.1016\/j.gmg.2026.100124_bib6","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1182\/blood-2012-06-435669","article-title":"Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial","volume":"120","author":"Yin","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.gmg.2026.100124_bib7","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1182\/blood-2003-03-0880","article-title":"New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts","volume":"102","author":"Schnittger","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.gmg.2026.100124_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.leu.2403627","article-title":"Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21)","volume":"19","author":"Leroy","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.gmg.2026.100124_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-981-10-3233-2_11","article-title":"RUNX1-ETO Leukemia","volume":"962","author":"Lin","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.gmg.2026.100124_bib10","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1038\/leu.2013.197","article-title":"JAK inhibitors suppress t(8;21) fusion protein-induced leukemia","volume":"27","author":"Lo","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.gmg.2026.100124_bib11","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1182\/blood-2013-03-488114","article-title":"Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors","volume":"123","author":"Bots","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.gmg.2026.100124_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nm1160","article-title":"Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway","volume":"11","author":"Insinga","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.gmg.2026.100124_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41408-021-00503-6","article-title":"Core binding factor acute myelogenous leukemia-2021 treatment algorithm","volume":"11","author":"Borthakur","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.gmg.2026.100124_bib14","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2017-04-777722","article-title":"Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis","volume":"130","author":"Magina","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.gmg.2026.100124_bib15","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/bloodadvances.2020003605","article-title":"Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)","author":"Han","year":"2021","journal-title":"Blood Adv. 5"},{"key":"10.1016\/j.gmg.2026.100124_bib16","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3324\/haematol.2018.192773","article-title":"RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells via KLF4-mediated transactivation of P57","volume":"104","author":"Liu","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.gmg.2026.100124_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2026.156607","article-title":"CBF\u03b2-SMMHC in inv(16) AML: Fusion biology, RUNX1 dysregulation, and therapeutic targeting of a leukemogenic protein-protein interaction","volume":"286","author":"Kamel","year":"2026","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.gmg.2026.100124_bib18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ccell.2018.08.015","article-title":"The oncogenic transcription factor RUNX1\/ETO corrupts cell cycle regulation to drive leukemic transformation","volume":"34","author":"Martinez-Soria","year":"2018","journal-title":"Cancer Cell."},{"key":"10.1016\/j.gmg.2026.100124_bib19","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.celrep.2014.08.024","article-title":"Identification of a dynamic core transcriptional network in t(8;21) AML that regulates differentiation block and self-renewal","volume":"8","author":"Ptasinska","year":"2014","journal-title":"Cell. Rep."},{"key":"10.1016\/j.gmg.2026.100124_bib20","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/leu.2012.49","article-title":"Depletion of RUNX1\/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding","volume":"26","author":"Ptasinska","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.gmg.2026.100124_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2407-4-44","article-title":"The oncogenic fusion protein RUNX1-CBFA2T1 supports proliferation and inhibits senescence in t(8;21)-positive leukaemic cells","volume":"4","author":"Martinez","year":"2004","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gmg.2026.100124_bib22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41375-023-01854-8","article-title":"Nanoparticle-mediated targeting of the fusion gene RUNX1\/ETO in t(8;21)-positive acute myeloid leukaemia","volume":"37","author":"Issa","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.gmg.2026.100124_bib23","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.1158\/0008-5472.CAN-17-0319","article-title":"RUNX1 upregulation by cytotoxic drugs promotes apoptosis","volume":"77","author":"Speidel","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.gmg.2026.100124_bib24","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1172\/JCI68557","article-title":"Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells","volume":"123","author":"Goyama","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gmg.2026.100124_bib25","article-title":"RUNX1 upregulates CENPE to promote leukemic cell proliferation","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.gmg.2026.100124_bib26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/jcb.22596","article-title":"RUNX1 repression-independent mechanisms of leukemogenesis by fusion genes CBFB-MYH11 and AML1-ETO (RUNX1-RUNX1T1)","volume":"110","author":"Hyde","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.gmg.2026.100124_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.70043","article-title":"Promoter-targeting RNA technologies: an epigenetic strategy for gene activation and gene silencing","volume":"17","author":"Hegde","year":"2026","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.gmg.2026.100124_bib28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/1087057116637562","article-title":"Small-activating RNA can change nucleosome positioning in human fibroblasts","volume":"21","author":"Wang","year":"2016","journal-title":"J. Biomol. Screen."}],"container-title":["Global Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2699940426000329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2699940426000329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:43:54Z","timestamp":1790595834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2699940426000329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2699940426000329"],"URL":"https:\/\/doi.org\/10.1016\/j.gmg.2026.100124","relation":{},"ISSN":["2699-9404"],"issn-type":[{"value":"2699-9404","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RUNX1 upregulation and RUNX1-ETO depletion inhibits survival of t(8;21)-positive leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Global Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gmg.2026.100124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100124"}}